조
조용준 Dirigeant
Other M
KR KR · DART (FSS)
Discover the complete record of transactions filed by 조용준, Dirigeant. Director active across 3 companies, notably 동구바이오제약. Cumulatively, 20 filings have been recorded. The latest transaction was filed on 22 April 2026 — Purchase. Regulator: DART (FSS). All data is free.
Declarations 20 total
0
DART:20260513000598 · 13 May 2026
Executives ● Purchase유 유비벨록스 15 DART €2,759 943 shares @ €2.9254 0.0000% mcap 100.0% of flow
DART:20260428000443 · 22 Apr 2026
Ideal exit: 17 Jan 2027 (T+270) Executives ● Purchase유 유비벨록스 15 DART €594 203 shares @ €2.9254 0.0000% mcap 100.0% of flow
DART:20260428000410 · 22 Apr 2026
Ideal exit: 17 Jan 2027 (T+270) Executives ● Purchase유 유비벨록스 2 DART €180,805 56,265 shares
DART:20260428000489 · 28 Apr 2026
Ideal exit: 23 Jan 2027 (T+270) Executives ● Purchase유 유비벨록스 30 DART €106,502 36,406 shares @ €2.9254 0.0001% mcap 100.0% of flow
DART:20260428000466 · 22 Apr 2026
Ideal exit: 17 Jan 2027 (T+270) Executives ● Purchase유 유비벨록스 15 DART €2,212 756 shares @ €2.9254 0.0000% mcap 100.0% of flow
DART:20260428000459 · 22 Apr 2026
Ideal exit: 17 Jan 2027 (T+270) Executives ● Purchase유 유비벨록스 15 DART €2,911 995 shares @ €2.9254 0.0000% mcap 100.0% of flow
DART:20260428000437 · 22 Apr 2026
Ideal exit: 17 Jan 2027 (T+270) Executives ● Purchase팅 팅크웨어 31 DART €16,552 3,472 shares @ €4.7674 0.0000% mcap 100.0% of flow
DART:20260423000611 · 17 Apr 2026
Ideal exit: 12 Jan 2027 (T+270) Executives ● Purchase팅 팅크웨어 16 DART €582 122 shares @ €4.7674 0.0000% mcap 100.0% of flow
DART:20260423000566 · 17 Apr 2026
Ideal exit: 12 Jan 2027 (T+270) Executives ● Purchase팅 팅크웨어 11 DART €570,887 119,749 shares @ €4.7674 0.0006% mcap 100.0% of flow
DART:20260423000627 · 17 Apr 2026
Ideal exit: 12 Jan 2027 (T+270) Executives ● Purchase팅 팅크웨어 3 DART €782,384 157,303 shares
DART:20260423000640 · 23 Apr 2026
Ideal exit: 18 Jan 2027 (T+270) Executives ● Purchase팅 팅크웨어 11 DART €204,806 42,960 shares @ €4.7674 0.0002% mcap 100.0% of flow
DART:20260422000083 · 17 Apr 2026
Ideal exit: 12 Jan 2027 (T+270) Executives ● Purchase팅 팅크웨어 3 DART €2,898 620 shares
DART:20260407000424 · 7 Apr 2026
Ideal exit: 2 Jan 2027 (T+270) Executives ● Purchase팅 팅크웨어 8 DART DART:20260406002689 · 6 Apr 2026
Ideal exit: 1 Jan 2027 (T+270) Executives ● Purchase팅 팅크웨어 8 DART DART:20260406002591 · 6 Apr 2026
Ideal exit: 1 Jan 2027 (T+270) 34,000 shares
DART:20260402002932 · 2 Apr 2026
Executives ● Other팅 팅크웨어 0 DART DART:20260316000365 · 16 Mar 2026 details not loaded
Executives ● Other팅 팅크웨어 0 DART DART:20260316000238 · 16 Mar 2026 details not loaded
DART:20260316000767 · 16 Mar 2026 details not loaded
Executives ● Other팅 팅크웨어 0 DART DART:20260310002527 · 10 Mar 2026 details not loaded
About 조용준 Jo Yong-jun is an executive at Donggu Bio Pharmaceutical, where he is involved in the operations and management of the company. While his specific role is not detailed, he contributes to the strategic direction and efficiency of processes within the organization, thereby supporting Donggu Bio Pharmaceutical's overall goals.